Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM

Clinical trial NCT04991870 · RECRUITING

Trial details

NCT number: NCT04991870
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Gliosarcoma Recurrent Supratentorial Glioblastoma Supratentorial Gliosarcoma

Start date: 2023-04-28
Primary completion: 2027-01-31
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.